| 项目编号 |
PRJCA027946 |
| 项目标题 |
A Phase III study of osimertinib as maintenance therapy in patients with locally advanced, unresectable EGFR mutation-positive NSCLC (Stage III) whose disease has not progressed |
| 涉及领域 |
Medical |
| 数据类型 |
Variation
|
| 物种名称 |
Homo sapiens
|
| 描述信息 |
To assess the efficacy of osimertinib treatment compared with placebo as measured by progression free survival (PFS) |
| 样品范围 |
Multiisolate |
| 发布日期 |
2024-07-10 |
| 项目资金来源 |
| 机构 |
项目类型 |
授权项目ID |
授权项目名称 |
| No funding support
|
|
|
|
|
|
| 提交者 |
shun
Lu (shunlu_shchest@sina.com)
|
| 提交单位 |
Shanghai Chest Hospital |
| 提交日期 |
2024-07-10 |
